|
| 產(chǎn)地 | 進(jìn)口、國(guó)產(chǎn) |
| 品牌 | 上海莼試 |
| 保存條件 | Store at -20 °C |
| 貨號(hào) | CS11841 |
| 應(yīng)用范圍 | WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500 |
| CAS編號(hào) | |
| 抗體名 | Anti- TRAF2 |
| 克隆性 | |
| 靶點(diǎn) | 詳見(jiàn)說(shuō)明書(shū) |
| 適應(yīng)物種 | 詳見(jiàn)說(shuō)明書(shū) |
| 形態(tài) | 詳見(jiàn)說(shuō)明書(shū) |
| 宿主 | 詳見(jiàn)說(shuō)明書(shū) |
| 亞型 | IgG |
| 標(biāo)識(shí)物 | 詳見(jiàn)說(shuō)明書(shū) |
| 濃度 | 1mg/1ml% |
| 免疫原 | KLH conjugated synthetic peptide derived from human TRAF2 C-terminus |
全、新、優(yōu)、品、好四大特點(diǎn)：
受體相關(guān)因子2抗體費(fèi)用 全：公司提供上萬(wàn)種產(chǎn)品，涵蓋了生物試劑，elisa試劑盒，標(biāo)準(zhǔn)品，培養(yǎng)基，原裝耗材，抗體、培養(yǎng)基、ATCC細(xì)胞等，基本上各種科研所需產(chǎn)品在我司都能找到。
新：產(chǎn)品更新速度較快，基本上每周都有新產(chǎn)品出現(xiàn)。
優(yōu)：產(chǎn)品質(zhì)量好，投訴比較少。
好：我公司具有優(yōu)質(zhì)的技術(shù)團(tuán)隊(duì)，產(chǎn)品一旦售出，實(shí)驗(yàn)過(guò)程中遇到困難可提供在線技術(shù)咨詢。使您使用產(chǎn)品時(shí)沒(méi)有任何的后顧之憂。
受體相關(guān)因子2抗體費(fèi)用 英文名稱 Anti- TRAF2
中文名稱 受體相關(guān)因子2抗體費(fèi)用
別 名 E3 ubiquitin-protein ligase TRAF2; MGC:45012; OTTHUMP00000022625; OTTHUMP00000064745; TNF receptor associated factor 2; TNF receptor-associated factor 2; TNF receptor-associated protein; TRAF 2; TRAF2; TRAF2_HUMAN; TRAP 3; TRAP; TRAP3; Tumor necrosis factor type 2 receptor associated protein 3; Tumor necrosis factor type 2 receptor-associated protein 3.
產(chǎn)品屬性：
濃 度 1mg/1ml
規(guī) 格 0.1ml/100μg 0.2ml/200μg
抗體來(lái)源 Rabbit
克隆類型 polyclonal
交叉反應(yīng) Human, Mouse, Rat
產(chǎn)品類型 一抗
研究領(lǐng)域 心 神經(jīng)生物學(xué) 信號(hào)轉(zhuǎn)導(dǎo) 細(xì)胞凋亡 生長(zhǎng)因子和激素 激酶和磷酸酶 細(xì)胞膜受體
蛋白分子量 predicted molecular weight: 56kDa
性 狀 Lyophilized or Liquid
免 疫 原 KLH conjugated synthetic peptide derived from human TRAF2 C-terminus
亞 型 IgG
純化方法 affinity purified by Protein A
儲(chǔ) 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide
受體相關(guān)因子2抗體費(fèi)用 產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
（石蠟切片需做抗原修復(fù)）
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
產(chǎn)品介紹 The induction of the various cellular responses mediated by tumor necrosis factor is initiated by its interaction with the TNFR1 and TNFR2 cell surface receptors. TRAF2 interacts with the cytoplasmic domain of TNFR2. TRAF2 is a common signal transducer for TNFR2 and CD40 that mediates activation of NF kappa B.
Function : Regulates activation of NF-kappa-B and JNK and plays a central role in the regulation of cell survival and apoptosis. Required for normal antibody isotype switching from IgM to IgG. Has E3 ubiquitin-protein ligase activity and promotes 'Lys-63'-linked ubiquitination of target proteins, such as BIRC3, RIPK1 and TICAM1. Is an essential constituent of several E3 ubiquitin-protein ligase complexes, where it promotes the ubiquitination of target proteins by bringing them into contact with other E3 ubiquitin ligases. Regulates BIRC2 and BIRC3 protein levels by inhibiting their autoubiquitination and subsequent degradation; this does not depend on the TRAF2 RING-type zinc finger domain. Isoform 2 does not seem to mediate activation of NF-kappa-B but inhibits isoform 1 activity. Plays a role in mediating activation of NF-kappa-B by EIF2AK2/PKR.
Subunit : Homotrimer, and heterotrimer with TRAF1 and TRAF3 (via TRAF domain). The domain containing the RING-type and the first TRAF-type zinc finger can also form homodimers (in vitro). Interacts with TNFRSF1B/TNFR2, TNFRSF4, TNFRSF5/CD40, CD27/TNFRSF7, TNFRSF8/CD30, TNFRSF9/CD137, TNFRSF11A/RANK, TNFRSF13B/TACI, TNFRSF14, TNFRSF16/NGFR, TNFRSF17/BCMA, TNFRSF18/AITR, TNFRSF19/TROY, TNFRSF19L/RELT, XEDAR, EDAR, Epstein-Barr virus BNFL1/LMP-1 and IL15RA. Interacts with CDK9, CSK, MAP3K1, MAP3K5, MAP3K11, MAP3K14, MAP4K2, RIPK1, RIPK2, TNIK, TBK1, SPHK1, TRADD, TRAFD1, TRAIP, TANK/ITRAF, TNFAIP3, TDP2, MAVS/IPS1, TICAM1 and TRPC4AP. Interacts with CASP8AP2, NFATC2IP, PEG3 and HIVEP3. Interacts with BIRC2 and BIRC3 N-terminus; a single BIRC2 or BIRC3 molecule interacts with a heterotrimer formed by TRAF1 and TRAF2, or a TRAF2 homotrimer. Identified in a complex composed of TRAF2, TRAF3, BIRC2 and/or BIRC3. Interaction with BIRC2 and/or BIRC3 is essential for degradation of NFKBIA and activation of NF-kappa-B. Interacts with CYLD, USP48, IKKA and IKKB. Interacts (via 'Lys-63'-linked polyubiquitin chains) with TAB2 and TAB3 (By similarity). Interaction with TAOK3 is facilitated under ER stress conditions, such as treatment with tunicamycin, and may promote TRAF2 phosphorylation (By similarity). Interacts with CASP12 under resting conditions; this interaction is reduced in ER stress conditions. Interacts (via zinc fingers) with DAB2IP (via C-terminus PER domain); the interaction occurs in a TNF-alpha-dependent manner (By similarity). Interacts with ERN1; the interaction requires DAB2IP. Interacts with DAB2IP. Interacts (via C-terminus) with EIF2AK2/PKR (via the kinase catalytic domain) (By similarity).
Subcellular Location : Cytoplasm.
Tissue Specificity : soform 1 and isoform 2 are expressed in spleen, adipose tissues, skeletal muscles, thymus, testis, heart, lung, brain. Isoform 2 is very weakly expressed in heart, lung and brain.
Post-translational modifications : Phosphorylated at several serine residues within the first 128 amino acid residues. Phosphorylated at Thr-117 in response to signaling via TNF and TNFRSF1A. Phosphorylation at Thr-117 is required for 'Lys-63'-linked polyubiquitination, but not for 'Lys-48'-linked polyubiquitination. Phosphorylation at Thr-117 is important for interaction with IKKA and IKKB, activation of IKK and subsequent activation of NF-kappa-B (By similarity).
Undergoes both 'Lys-48'-linked and 'Lys-63'-linked polyubiquitination. Polyubiquitinated via 'Lys-63'-linked ubiquitin in response to TNF signaling; this requires prior phosphorylation at Thr-117. 'Lys-63'-linked polyubiquitination promotes TRAF2-mediated activation of NF-kappa-B. Can be polyubiquitinated at several Lys residues via 'Lys-48'-linked ubiquitin chains in response to TNF signaling, leading to proteasomal degradation. Autoubiquitinated, leading to its subsequent proteasomal degradation. Polyubiquitinated by BIRC2 and SIAH2, leading to its subsequent proteasomal degradation. Not ubiquitinated by BIRC3 or SIAH1. Deubiquitinated by CYLD, a protease that specifically cleaves 'Lys-63'-linked polyubiquitin chains (By similarity).
Similarity : Belongs to the TNF receptor-associated factor family. A subfamily.
Contains 1 MATH domain.
Contains 1 RING-type zinc finger.
Contains 2 TRAF-type zinc fingers.
Database links :
UniProtKB/Swiss-Prot: P39429.1
Entrez Gene: 7186 Human
Entrez Gene: 22030 Mouse
Entrez Gene: 311786 Rat
Omim: 601895 Human
SwissProt: Q12933 Human
SwissProt: P39429 Mouse
Unigene: 522506 Human
Unigene: 3399 Mouse
信號(hào)傳導(dǎo)（Signaling Intermediates）
TRAF2在介導(dǎo)細(xì)胞凋亡信號(hào)及在細(xì)胞的凋亡中發(fā)揮著一定的作用。TRAF2分布較廣泛，在所有檢測(cè)的組織中都有表達(dá)，包括、腦、*、肺、肝、骨骼肌、腎和睪丸等，TRAF2可以介導(dǎo)TNFRII、CD40、CD30和EV轉(zhuǎn)化蛋白LMP1活化NF-kB。
實(shí)驗(yàn)流程：
正在熱銷的相關(guān)產(chǎn)品：
Eotaxin human 人噬酸性粒細(xì)胞趨化因子Multi-class antibodies
Anti-phospho C-Myc(Thr58/pSer62) 磷酸化致癌基因C-Myc抗體Multi-class antibodies規(guī)格： 0.1ml
Rhesus antibody Rh NPD014 1號(hào)染色體開(kāi)放閱讀框63抗體 規(guī)格 0.1ml
FASL ELISA Kit 小鼠凋亡相關(guān)因子配體 96T
TRIB3 英文名稱： 神經(jīng)細(xì)胞死亡誘導(dǎo)蛋白激酶抗體 0.1ml
C6orf25 英文名稱： 6號(hào)染色體開(kāi)放閱讀框25抗體 0.2ml
Anti-phospho C-Myc(Thr58/pSer62) 磷酸化致癌基因C-Myc抗體Multi-class antibodies規(guī)格： 0.1ml
PGF ELISA Kit 大鼠素FMulti-class antibodies規(guī)格： 48T
Anti-ASK1/MAPKKK5 /FITC 熒光素標(biāo)記細(xì)胞凋亡信號(hào)調(diào)節(jié)激酶1/原活化蛋白激酶激酶激酶5抗體IgGMulti-class antibodies規(guī)格： 0.2ml
Rhesus antibody Rh FAM120B 組織激活過(guò)氧化酶活化增生受體γ蛋白抗體 規(guī)格 0.2ml
IFI16/p16(Human interferon-inducible protein 16) ELISA Kit 人γ干擾素誘導(dǎo)蛋白16/p16 96T
MMP-7 英文名稱： 基質(zhì)金屬蛋白酶-7抗體 0.1ml
ALDH1A2 英文名稱： 乙醛脫氫酶2型抗體 0.1ml
Anti-ASK1/MAPKKK5 /FITC 熒光素標(biāo)記細(xì)胞凋亡信號(hào)調(diào)節(jié)激酶1/原活化蛋白激酶激酶激酶5抗體IgGMulti-class antibodies規(guī)格： 0.2ml
Anti-TFPI/LACI /FITC 熒光素標(biāo)記組織因子途徑抑制劑抗體IgGMulti-class antibodies規(guī)格： 0.2ml
ASPP1(apoptosis stimulating protein of P53 1) p53凋亡刺激蛋白1抗原Multi-class antibodies規(guī)格： 0.5mg
蛋白抗體 Anti-Snake poison Protein 0.2ml
Synaptopodin 英文名稱： 突觸足蛋白抗體 0.1ml
ETS2 英文名稱： 癌基因ETS2抗體 0.1ml
Rhesus antibody Rh phospho-MAPKAPK5(Thr182) 磷酸化p38調(diào)節(jié)/激活蛋白激酶抗體 規(guī)格 0.1ml
ASPP1(apoptosis stimulating protein of P53 1) p53凋亡刺激蛋白1抗原Multi-class antibodies規(guī)格： 0.5mg
大鼠黏著斑蛋白(VCL)ELISA試劑盒 ，英文名： VCL ELISA Kit
人P53(P53)ELISA檢測(cè)試劑盒Humanp53/tumorprotein,p53/TP53ELISAKit 96T/48T
魚(yú)雌二醇(E2)免疫試劑盒 Fish Esadiol,E2ELISA kit
CLIAKitforPCK(Humanphosphoenolpyruvatecarboxykinase)ELISAKit人磷酸烯醇式同酸羧激酶規(guī)格：48T/96T
樹(shù)脂法微量全血DNA純化試劑盒20次
ELISAKitC3人補(bǔ)體蛋白3規(guī)格：48T/96T
大鼠雌激素(E)ELISA 試劑盒 96T/48T 試劑盒 組裝/原裝
人免疫球蛋白M(IgM)免疫試劑盒 Human Immunoglobulin M,IgM ELISA Kit
MouseTumornecrosisfactorsolublereceptorⅡ,TNFsR-ⅡELISAKit小鼠壞死因子可溶性受體Ⅱ(TNFsR-Ⅱ)ELISA試劑盒規(guī)格：96T/48T
石蠟切片組織AKT蛋白表達(dá)NBT顯色光學(xué)顯微鏡檢測(cè)試劑盒10/20次
HumanProinsulin,PIELISA試劑盒人胰島素原(PI)ELISA試劑盒規(guī)格：96T/48T
Humahrombomodulin，TMELISAKit人調(diào)節(jié)蛋白(TM)ELISA試劑盒規(guī)格：96T/48T
受體相關(guān)因子2抗體費(fèi)用 大鼠二級(jí)淋巴組織趨化因子(SLC/CCL21)ELISA試劑盒 ，英文名： SLC/CCL21 ELISA Kit
Brain naiuretic peptide brain naiuretic peptide (BNP) ELISA Kit 豬腦素/腦尿肽(BNP)ELISA試劑盒
鹿特定基因序列(Deer)核酸檢測(cè)試劑盒(PCR-熒光探針?lè)? 48T
CLIAKitforM2-PKELISAKit大鼠同酸激酶M2型同工酶規(guī)格：48T/96T
體液總氨基酸含量熒光定量檢測(cè)試劑盒20次
ELISAKitLPS雞脂多糖/內(nèi)毒素規(guī)格：48T/96T
技術(shù)外包服務(wù):
★受體相關(guān)因子2抗體費(fèi)用 分子生物學(xué)：質(zhì)粒抽提、PCR、Q-PCR、RT-PCR、分子生物學(xué)：基因合成、引物合成、基因測(cè)序、載體構(gòu)建等
★蛋白工程：原核、哺乳動(dòng)物蛋白表達(dá)系統(tǒng)等
★病毒包裝：腺病毒、慢病毒等
★抗體工程：磁珠分選、病理染色、WB、ELISA、IP、IF、IHC、FACS、Confocal等等
★細(xì)胞工程：細(xì)胞表型分析(凋亡、增殖、周期、遷移、侵襲、修復(fù)、克隆形成)、細(xì)胞培養(yǎng)、細(xì)胞膜制備、穩(wěn)定細(xì)胞株構(gòu)建、細(xì)胞RNAi技術(shù)等等。
|
|
|
|
|
